In this Healthed lecture, Prof Andrew Sindone will discuss the ever lower targets for LDL-C particularly in secondary prevention as well as presenting data that shows even high risk populations are failing to meet these targets. He will also discuss the latest available therapy for persistently elevated LDL-C levels that has proven benefits in terms of effectiveness, safety, accessibility and compliance.

H5N1 avian influenza: Global threats, local preparedness and key risk groups
27:09

Long COVID Part 2 – Treatment
41:27

COVID surge update, booster news, new vaccine and more
29:32